Infectious disease
)
Rapid access to results
Offering comprehensive, real-time insights into the genomics of infectious diseases — from pathogen identification and antimicrobial resistance (AMR) profiling to the assembly of high-quality genomes and variant identification — Oxford Nanopore sequencing delivers immediate access to the critical genomic epidemiology data required to effectively control infectious disease outbreaks.
Sequence in the lab or at sample source at a scale that suits your needs, with powerful portable and high-throughput Oxford Nanopore sequencing devices.
Featured content
)
Pathogen metagenomics
Metagenomic sequencing is a key technique for the identification of potential pathogens. This end-to-end workflow overview introduces how to rapidly identify bacterial, fungal, and viral pathogens from respiratory research samples using metagenomic sequencing.
)
Delivering the future of genomic pathogen surveillance
Find out how nanopore sequencing overcomes the limitations of legacy genomic analysis technologies to deliver rapid, affordable, and informative results for a range of pathogen outbreaks, including SARS-CoV-2, Zika, Ebola, and many more — improving surveillance of infectious diseases.
)
)
)
Preventing pandemics
AmPORE-TB
AmPORE-TB is a research workflow that delivers rapid characterisation of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis, species identification, and lineage identification in a single assay, directly from sputum samples.
Combining fast library preparation with on-demand nanopore sequencing and hands-off, comprehensive analysis onboard the GridION AmPORE-TB device, the AmPORE-TB workflow can take as little as six hours for same-day results.
The GridION AmPORE-TB device, installed with the AmPORE-TB data analysis software, will be distributed by bioMérieux (Q-GRD-MK1-ATB).
Recommended device for infectious disease sequencing
)
GridION
A compact benchtop device designed to run and analyse up to five MinION Flow Cells. Run multiple experiments on a single device, on-demand — ideal for rapid and scalable analysis of pathogen samples and tracking novel variants.
